The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands

References

• Mencke T, Echternach M, Kleinschmidt S, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology. 2003;98(5):1049–1056. doi:10.1097/00000542-200305000-00005
   PubMed Web of Science ®Google Scholar
• Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014;112(3):498–505. doi:10.1093/bja/aet377
   PubMed Web of Science ®Google Scholar
• Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001;56(4):312–318. doi:10.1046/j.1365-2044.2001.01921.x
   PubMed Web of Science ®Google Scholar
• Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98(5):1042–1048. doi:10.1097/00000542-200305000-00004
   PubMed Web of Science ®Google Scholar
• Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41(9):1095–1103. doi:10.1111/j.1399-6576.1997.tb04851.x
   PubMed Web of Science ®Google Scholar
• Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130–137. doi:10.1213/ane.0b013e31816d1268
   PubMed Web of Science ®Google Scholar
• Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41(2):266–270. doi:10.1002/1521-3773(20020118)41:2<265::aid-anie265>3.0.co;2-q
   PubMed Web of Science ®Google Scholar
• Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology. 2008;109(5):816–824. doi:10.1097/ALN.0b013e31818a3fee
   PubMed Web of Science ®Google Scholar
• Rao Kadam V, Howell S. Unrestricted and restricted access to sugammadex and side effect profile in a teaching hospital centre for year 2014- database audit study. Anesth Pain Med. 2018;8(1):e63066. doi:10.5812/aapm.63066
   PubMedGoogle Scholar
• Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth. 2015;115(5):743–751. doi:10.1093/bja/aev104
   PubMed Web of Science ®Google Scholar
• Krause M, McWilliams SK, Bullard KJ, et al. Neostigmine versus sugammadex for reversal of neuromuscular blockade and effects on reintubation for respiratory failure or newly initiated noninvasive ventilation: an interrupted time series design. Anesth Analg. 2020;131(1):141–151. doi:10.1213/ANE.0000000000004505
   PubMed Web of Science ®Google Scholar
• Kheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020;132(6):1371–1381. doi:10.1097/ALN.0000000000003256
   PubMed Web of Science ®Google Scholar
• Togioka BM, Yanez D, Aziz MF, Higgins JR, Tekkali P, Treggiari MM. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery. Br J Anaesth. 2020;124(5):553–561. doi:10.1016/j.bja.2020.01.016
   PubMed Web of Science ®Google Scholar
• Li G, Freundlich RE, Gupta RK, et al. Postoperative pulmonary complications’ association with sugammadex versus neostigmine: a retrospective registry analysis. Anesthesiology. 2021;134(6):862–873. doi:10.1097/ALN.0000000000003735
   PubMed Web of Science ®Google Scholar
• Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017;8:CD012763. doi:10.1002/14651858.CD012763
   PubMed Web of Science ®Google Scholar
• Bash LD, Turzhitsky V, Black W, Urman RD. Neuromuscular blockade and reversal agent practice variability in the US inpatient surgical settings. Adv Ther. 2021;38(9):4736–4755. doi:10.1007/s12325-021-01835-2
   PubMed Web of Science ®Google Scholar
• Kirmeier E, Eriksson LI, Lewald H, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7(2):129–140. doi:10.1016/S2213-2600(18)30294-7
   PubMed Web of Science ®Google Scholar
• Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ. 2012;345:e6329. doi:10.1136/bmj.e6329
   PubMed Web of Science ®Google Scholar
• Dubovoy TZ, Saager L, Shah NJ, et al. Utilization patterns of perioperative neuromuscular blockade reversal in the United States: a retrospective observational study from the multicenter perioperative outcomes group. Anesth Analg. 2020;131(5):1510–1519. doi:10.1213/ANE.0000000000005080
   PubMed Web of Science ®Google Scholar
• Bash LD, Black W, Turzhitsky V, Urman RD. Neuromuscular blockade and reversal practice variability in the outpatient setting: insights from US utilization patterns. Anesth Analg. 2021;133(6):1437–1450. doi:10.1213/ANE.0000000000005657
   PubMed Web of Science ®Google Scholar
• Ledowski T, Hillyard S, Kozman A, et al. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intensive Care. 2012;40(2):340–343. doi:10.1177/0310057X1204000219
   PubMed Web of Science ®Google Scholar